CYP3A4 inhibitors (CYP3A4i) and myelosuppression in patients (Pts) with newly diagnosed mutant isocitrate dehydrogenase 1 (mIDH1) Acute Myeloid Leukemia (AML) in the phase 3 AGILE study
Por:
Schuh, A, Montesinos, P, Recher, C, Heuser, M, Vives, S, Zarzycka, E, Riva, M, Calado, R, Yeh, SP, Dinardo, C, Hossain, M, Hui, JA, Gianolio, D, Vestin, A, Ding, R, Patel, P, De Botton, S, Döhner, H and Wang, JX
Publicada:
3 nov 2025
Ahead of Print:
1 ene 2025
Resumen:
Filiaciones:
Schuh, A:
Princess Margaret Canc Ctr, Toronto, ON, Canada
Montesinos, P:
Hosp Univ & Politecn La Fe, Valencia, Spain
Recher, C:
Univ Toulouse, Inst Univ Canc Toulouse Oncopole, CHU Toulouse, Toulouse, France
Heuser, M:
Martin Lutzer Univ Halle Wittenberg, Hannover Med Sch, Halle Wittenberg, Germany
:
Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol ICO Badalona, Josep Carreras Res Inst, Badalona, Spain
Zarzycka, E:
Med Univ Gdansk, Dept Hematol & Transplantol, Gdansk, Poland
Riva, M:
ASST Grande Osped Metropolitano Niguarda, Dept Hematol Oncol & Mol Med, Milan, Italy
Calado, R:
Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil
Yeh, SP:
China Med Univ, Taichung, Taiwan
Dinardo, C:
Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX USA
Hossain, M:
Servier BioInnovat, Boston, MA USA
Hui, JA:
Servier BioInnovat, Boston, MA USA
Gianolio, D:
Servier BioInnovat, Boston, MA USA
Vestin, A:
Servier BioInnovat, Boston, MA USA
Ding, R:
Servier BioInnovat, Boston, MA USA
Patel, P:
Servier BioInnovat, Boston, MA USA
De Botton, S:
Inst Gustave Roussy, Fac Paris Saclay, Villejuif, France
Döhner, H:
Ulm Univ Hosp, Ulm, Germany
Wang, JX:
Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
Bronze
|